Innovent Biologics, Inc. (HKG:1801)

Innovent Biologics Statistics

Total Valuation

HKG:1801 has a market cap or net worth of HKD 170.59 billion. The enterprise value is 163.84 billion.

Market Cap	170.59B
Enterprise Value	163.84B

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1801 has 1.71 billion shares outstanding. The number of shares has increased by 3.74% in one year.

Current Share Class	1.71B
Shares Outstanding	1.71B
Shares Change (YoY)	+3.74%
Shares Change (QoQ)	+3.84%
Owned by Insiders (%)	6.48%
Owned by Institutions (%)	42.01%
Float	1.59B

Valuation Ratios

The trailing PE ratio is 134.73 and the forward PE ratio is 104.19.

PE Ratio	134.73
Forward PE	104.19
PS Ratio	13.63
PB Ratio	10.79
P/TBV Ratio	11.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	132.05
EV / Sales	13.09
EV / EBITDA	106.12
EV / EBIT	130.97
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.23.

Current Ratio	2.61
Quick Ratio	2.25
Debt / Equity	0.23
Debt / EBITDA	2.29
Debt / FCF	n/a
Interest Coverage	13.27

Financial Efficiency

Return on equity (ROE) is 8.43% and return on invested capital (ROIC) is 4.49%.

Return on Equity (ROE)	8.43%
Return on Assets (ROA)	3.44%
Return on Invested Capital (ROIC)	4.49%
Return on Capital Employed (ROCE)	6.49%
Revenue Per Employee	2.02M
Profits Per Employee	200,446
Employee Count	5,659
Asset Turnover	0.52
Inventory Turnover	2.97

Taxes

In the past 12 months, HKG:1801 has paid 86.32 million in taxes.

Income Tax	86.32M
Effective Tax Rate	6.50%

Stock Price Statistics

The stock price has increased by +138.56% in the last 52 weeks. The beta is 0.21, so HKG:1801's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	+138.56%
50-Day Moving Average	93.26
200-Day Moving Average	58.65
Relative Strength Index (RSI)	52.84
Average Volume (20 Days)	20,216,780

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1801 had revenue of HKD 12.52 billion and earned 1.24 billion in profits. Earnings per share was 0.74.

Revenue	12.52B
Gross Profit	9.56B
Operating Income	1.32B
Pretax Income	1.33B
Net Income	1.24B
EBITDA	1.61B
EBIT	1.32B
Earnings Per Share (EPS)	0.74

Balance Sheet

The company has 10.45 billion in cash and 3.70 billion in debt, giving a net cash position of 6.75 billion or 3.94 per share.

Cash & Cash Equivalents	10.45B
Total Debt	3.70B
Net Cash	6.75B
Net Cash Per Share	3.94
Equity (Book Value)	15.80B
Book Value Per Share	9.62
Working Capital	8.85B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 76.34%, with operating and profit margins of 10.56% and 9.91%.

Gross Margin	76.34%
Operating Margin	10.56%
Pretax Margin	10.60%
Profit Margin	9.91%
EBITDA Margin	12.90%
EBIT Margin	10.56%
FCF Margin	n/a

Dividends & Yields

HKG:1801 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.74%
Shareholder Yield	n/a
Earnings Yield	0.73%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5